Showing results (2191-2200 of 2,239) with videos related to
Sort By:
Pageof 224
The Lancet. Oncology|June 21, 2013
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trialYi-Long Wu, Jin Soo Lee, Sumitra Thongprasert, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonistsMichael Berlin, Pauline C Ting, Wayne D Vaccaro, et al.BMC Medicine|July 1, 2026
Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysisJun-Long Wu, Shu-Suan Jiang, Hong Luo, et al.JTO Clinical and Research Reports|January 3, 2022
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN StudyXue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 7, 2018
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)Song-Tao Xu, Jun-Jie Xi, Wen-Zhao Zhong, et al.JAMA Oncology|June 13, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSong Dong, Zhen Wang, Jia-Tao Zhang, et al.Eclinicalmedicine|October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trialSi-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.Microbiology Spectrum|August 5, 2024
Effect of multifunctional cationic polymer coatings on mitigation of broad microbial pathogensJianliang Gong, Chun-Yin Or, Eric Tung-Po Sze, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2026
LAMPAD:An Integrated ctDNA-Based Model for Predicting Potential Cure in Resected NSCLC PatientsJia-Tao Zhang, Ke-Zhong Chen, Xuan Gao, et al.Pageof 224